IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,128,960 | +918.1% | 107,553 | +403.1% | 0.01% | – |
| Q2 2023 | $405,560 | +55.5% | 21,379 | +27.1% | 0.00% | – |
| Q1 2023 | $260,801 | -12.6% | 16,815 | 0.0% | 0.00% | – |
| Q4 2022 | $298,466 | +246.9% | 16,815 | +9.1% | 0.00% | – |
| Q3 2022 | $86,027 | +43.4% | 15,417 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -29.4% | 15,417 | 0.0% | 0.00% | – |
| Q1 2022 | $85,000 | -35.1% | 15,417 | 0.0% | 0.00% | – |
| Q4 2021 | $131,000 | -1.5% | 15,417 | +0.9% | 0.00% | – |
| Q3 2021 | $133,000 | -17.9% | 15,282 | 0.0% | 0.00% | – |
| Q2 2021 | $162,000 | -41.3% | 15,282 | -11.2% | 0.00% | -100.0% |
| Q1 2021 | $276,000 | -62.3% | 17,215 | +8.7% | 0.00% | 0.0% |
| Q4 2020 | $732,000 | +77.7% | 15,838 | +35.4% | 0.00% | 0.0% |
| Q3 2020 | $412,000 | – | 11,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |